Sectors

VTVT
vTv Therapeutics Inc.
32.00
3 x 31.50
1 x 32.80
bid
ask
-
0.36
1.11%
2 @ 04:10 PM
32.00 +0.00 (0.00%)
Ytd-19.98%
1y97.04%
31.35
day range
32.22
17.00
52 week range
44.00
Open31.88Prev Close32.36Low31.35High32.22Mkt Cap126.53M
Vol94.15KAvg Vol74.03KEPS-0.75P/EN/AForward P/E-42.03
Beta0.63Short Ratio1.50Inst. Own14.95%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg33.26200-d Avg34.321yr Est35.00
Income Statement
Operating Expenses13.90M
Research and Development Expense8.77M
Selling, General and Administrative Expense5.16M
Operating Income-13.89M
Net Income-13.05M
Net Income Common Stock-13.05M
Net Income Common Stock (USD)-13.05M
Consolidated Income-13.05M
Earnings per Basic Share-1.05
Earnings per Basic Share (USD)-1.05
Earnings per Diluted Share-1.05
Earning Before Interest & Taxes (EBIT)-13.05M
Earning Before Interest & Taxes (USD)-13.05M
Weighted Average Shares12.41M
Weighted Average Shares Diluted12.41M
Balance Sheet
Cash and Equivalents86.64M
Cash and Equivalents (USD)86.64M
Current Assets87.59M
Total Assets87.59M
Current Liabilities7.02M
Total Liabilities8.96M
Accumulated Retained Earnings (Deficit)-315.61M
Shareholders Equity78.63M
Shareholders Equity (USD)78.63M
Assets Non-Current4.00K
Deferred Revenue1.83M
Liabilities Non-Current1.94M
Trade and Non-Trade Payables6.99M
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow / Change in Cash & Cash Equivalents-11.44M
Net Cash Flow from Operations-11.44M
Share Based Compensation1.73M